- For Print
- November 26, 2020
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has commenced the “PaDiCo” smartphone application service in Japan to support the lives of patients with Parkinson’s disease. The app is available for free download via the App Store (iPhone) or Google Play (Android).
It is estimated that the number of patients with Parkinson’s disease in Japan is approximately 200,000,1 and the number of patients tends to increase year by year with the aging of the population.1, 2 The basic treatment for Parkinson’s disease is drug therapy.2 However, as the disease progresses, the medication is no longer working effectively, and wearing-off phenomenon in Parkinson’s disease may occur, such as total or partial immobility.
The wearing-off phenomenon are diverse, including the motor symptoms such as tremor and muscular rigidity (stiffness), and the non-motor symptoms such as constipation, pollakiuria and sweating. Thus, it is considered to be difficult to understand wearing-off phenomenon. Understanding these symptoms at an early stage and providing patients with appropriate treatments may help control the progression of the disease.
The PaDiCo is equipped with a function that allows, with a simple operation, patients with Parkinson’s disease to record the time when wearing-off phenomenon appeared and visualize it on a weekly basis. In addition, the PaDiCo enables patients, in prior to visiting a medical institution, to score the fluctuations in their physical conditions and symptoms at that time and record it on the app. Recording the patient’s daily conditions is useful to patients for accurately relaying symptoms to their attending physicians. Furthermore, patients can send alerts or messages to pre-registered family members and close friends via SMS (Short Message Service) function of the PaDiCo by simply pressing the access button of the application displayed on the smartphone screen, for times such as their symptoms are severe. Besides, this app features an SOS display function, drug management, and useful information for patients in daily life such as a comprehensive exercise program recommendable for patients with Parkinson’s disease.
Eisai focuses on continuously creating new drugs in the field of Parkinson’s disease whilst delivering Parkinson’s disease treatment Equfina® with a novel mechanism of action in Japan. We will, beyond providing drugs, further contribute to improving the QOL (quality of life) of patients with Parkinson’s disease and assisting their families to liven up a daily life by disseminating information through the PaDiCo and the PD Net, the Parkinson’s disease information site operated by Eisai.
Public Relations Department,
Eisai Co., Ltd.
[Notes to editors]
About key features of the PaDiCo App *This app is not a medical device.
The name PaDiCo comes from a combination of the underlined letters of Parkinson, Digital, and Communication. The app is equipped with various functions for patients with Parkinson’s disease; such as recording and visualizing off” time, recording their conditions and symptoms, an auxiliary function for sending messages, an SOS display function, and enabling users to receive useful information for a daily life such as a comprehensive exercise program recommendable for the patients with Parkinson’s disease.
A function that allows users with a simple operation to record “off” time and visualize it on a weekly basis, and a function to record the physical conditions and symptoms of patients with Parkinson’s disease
An auxiliary function for sending messages, an SOS display function, and a function to provide useful information for daily life of the patients with Parkinson’s disease such as recommended exercise training programs
PaDiCo Information Desk: firstname.lastname@example.org (available in Japanese only).
Information on how to use the app is available through the Parkinson’s disease information website “PD Net”.
https://patients.eisai.jp/pdnet/ (available in Japanese only)
PD Net is a website for an accurate understanding of symptoms and progression of Parkinson’s disease. Also, PD Net provides useful information to patients with Parkinson’s disease and their families to have better understanding of the disease and the consultation at hospital.
Japanese Society of Neurology “Parkinson’s disease clinical practice guideline 2018”
Japan Intractable Diseases Information Center – Parkinson’s disease (designated intractable disease 6):
https://www.nanbyou.or.jp/entry/169 (available in Japanese only)